Abstract
Isolated systolic hypertension affects over 15% of all subjects older than 60 years.
In the elderly, systolic hypertension is the major modifiable cardiovascular risk
factor. Three placebo-controlled outcome trials on antihypertensive drug treatment
for this disorder have been published. The aim of this article was to briefly review
the main findings of each of these three trials and to present pooled estimates of
the benefit of antihypertensive drug treatment in isolated systolic hypertension in
the elderly. A total of 11 825 patients were enrolled in the Systolic Hypertension
in the Elderly Program (SHEP; N=4736) in the United States, and in the Systolic Hypertension in Europe (Syst-Eur;
N=4695) and the Systolic Hypertension in China (Syst-China; N=2394) trials. The outcome results of these trials were pooled by calculating the
common odds ratio for active vs. placebo treatment. Overall, compared to placebo,
active treatment reduced all-cause mortality by 17%, cardiovascular mortality by 25%,
all cardiovascular endpoints by 32%, total stroke by 37%, and myocardial infarction
including sudden death by 25%. Thus, the pooled results of the outcome trials in older
patients with isolated systolic hypertension prove that antihypertensive drug treatment
must be prescribed if, on repeated measurement, systolic blood pressure is 160 mmHg
or higher.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Evaluation of cardiovascular risk in the elderly: the Framingham study.Bull NY Acad Med. 1978; 54: 573-591
- Amery A: the increase in blood pressure with age and body mass index is overestimated by conventional sphygmomanometry.Am J Epidemiol. 1992; 136: 450-459
- Editorial review. Isolated systolic hypertension in the elderly.J Hypertens. 1990; 8: 393-405
- The prognosis of hypertension according to age at onset.Hypertension. 1987; 9: 204-208
- Why is antihypertensive drug therapy needed in elderly patients with systolodiastolic hypertension?.J Hypertens. 1994; 12 (suppl 6): S25-S34
- Implications of the systolic hypertension in the elderly program.Hypertension. 1993; 21: 335-343
- For the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators: randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension.Lancet. 1997; 350: 757-764
- For the Systolic Hypertension in China (Syst-China) Collaborative Group: comparison of active treatment and placebo for older patients with isolated systolic hypertension.J Hypertens. 1998; 16: 1823-1829
- Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP).JAMA. 1991; 265: 3255-3264
- For the Systolic Hypertension in the Elderly Cooperative Research Group: effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension.JAMA. 1996; 276: 1886-1892
- Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol and organization.Aging Clin Exp Res. 1991; 3: 287-302
- For the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators: subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly.Arch Intern Med. 1998; 158: 1681-1691
- Implications for trials in progress of publication of positive results.Lancet. 1993; 342: 653-657
- Systolic Hypertension in the Elderly Program (SHEP) and Swedish Trial in Old Patients With Hypertension (STOP). The promises and the potential problems.Am J Hypertens. 1992; 5: 331-334
- Some lessons from Systolic Hypertension in the Elderly Program (SHEP).Am J Hypertens. 1992; 5: 325-330
- Isolated systolic hypertension in the elderly: implications of SHEP for clinical practice and for the ongoing trials.J Hum Hypertens. 1991; 5: 469-474
- Inverse association between baseline pressure and benefit from treatment in isolated systolic hypertension.Hypertension. 1994; 23: 269-270
- Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.Circulation. 1995; 92: 1326-1331
- The risk of myocardial infarction associated with antihypertensive drug therapies.JAMA. 1995; 274: 620-625
- For the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators: calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension.Hypertension. 1998; 32: 404-409
- For the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators, Staessen JA: effects of calcium-channel blockage in older patients with diabetes and systolic hypertension.N Engl J Med. 1999; 340: 677-684
- Is prevention of vascular dementia possible? The Syst-Eur Vascular Dementia Project.Aging Clin Exp Res. 1991; 3: 373-382
- Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project.J Hypertens. 1998; 16: 963-969
- On behalf of the Syst-Eur Investigators: prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.Lancet. 1998; 352: 1347-1351
- `Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician.J Psychiat Res. 1975; 12: 189-198
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington DC, USA, 1987.
- Systolic hypertension in the elderly: Chinese trial (Syst-China) — interim report.Chin J Cardiol. 1992; 20: 270-275
- On behalf of the Syst-China Investigators: Long-term blood pressure control in older Chinese patients with isolated systolic hypertension: a progress report on the Syst-China trial.J Hum Hypertens. 1996; 10: 735-742
Wang JG, Staessen JA, Gong L, Liu L. For the Systolic Hypertension in China Investigator: subgroup analysis of the placebo-controlled Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med 1999, in press.
- A meta-analysis of outcome trials in elderly hypertensives.J Hypertens. 1992; 10: 1103-1109
Staessen JA, Wang JG. Benefit of antihypertensive drug treatment in older patients with isolated systolic hypertension. Eur Heart J 1999, in press.
- Benefits and potential harm of lowering high blood pressure.Lancet. 1987; i: 581-583
Article info
Publication history
Accepted:
April 13,
1999
Received in revised form:
April 12,
1999
Received:
April 6,
1999
Identification
Copyright
© 1999 Elsevier Science B.V. Published by Elsevier Inc. All rights reserved.
